Rhomboid protease RHBDL2 is a calcium-activated suppressor of EGFR signalling in keratinocytes.

The study reveals that the human rhomboid protease RHBDL2 acts as a calcium-activated suppressor of EGFR signaling in keratinocytes by shedding the receptor's ectodomain, thereby limiting cell migration and invasion while promoting proper skin differentiation.

The Gist

The Big Picture: A Cellular "Traffic Cop"

Imagine your skin is a bustling city made of millions of tiny buildings called keratinocytes (skin cells). For this city to function, the buildings need to communicate. They send out messages (signals) to tell each other when to grow, move, or change shape.

The main "phone line" for these messages is a receptor on the cell surface called EGFR. Think of EGFR as a doorbell. When the right person (a growth factor ligand) rings the doorbell, the cell gets the message to start working (like moving to heal a cut or dividing to make new skin).

However, if the doorbell rings too much, the cell gets confused, grows uncontrollably, or moves where it shouldn't (which can lead to cancer or poor skin healing). The city needs a way to stop the doorbell from ringing constantly.

Enter RHBDL2. This paper discovers that RHBDL2 is a special cellular traffic cop that acts as a "decoy" to stop the doorbell from ringing too loudly.

---

The Story in Three Acts

Act 1: The Secret Saboteur (What is RHBDL2?)

Scientists were trying to figure out what the protein RHBDL2 actually does in human skin cells. They knew it was a "protease," which is basically a pair of molecular scissors. But what was it cutting?

Using a high-tech "molecular camera" (proteomics), they found that RHBDL2's favorite target is the EGFR doorbell itself.

• The Analogy: Imagine the EGFR doorbell is a heavy, metal object attached to the wall. RHBDL2 is a skilled thief who sneaks up, snips the doorbell off the wall, and throws it into the street.
• The Result: Once the doorbell is cut off, it floats around in the "street" (the space between cells). This floating piece is called the ectodomain. It looks exactly like the real doorbell, so when the growth factor messages try to ring the real doorbell, they get distracted and ring the fake floating one instead.
• The Effect: The real doorbell stays silent. The cell stops getting the "grow and move" signal. RHBDL2 is essentially suppressing the signal to keep the cell calm.

Act 2: The Calcium Switch (When does it happen?)

The scientists noticed something fascinating: RHBDL2 doesn't just cut the doorbell all the time. It has a special activation switch.

• The Analogy: Think of RHBDL2 as a security guard who is usually asleep. But, if the building's fire alarm (which in this case is a rise in Calcium) goes off, the guard wakes up immediately.
• The Science: In skin cells, calcium levels rise when the cells are ready to differentiate (mature and turn into the tough, outer layer of skin). When calcium rises, RHBDL2 wakes up, grabs its scissors, and starts cutting the EGFR doorbells.
• Why? This ensures that when skin cells are ready to become the tough, protective outer layer, they stop moving and dividing. They need to stop "running around" and start "building the wall."

Act 3: What Happens When the Cop is Missing?

To prove this theory, the scientists created skin cells that were missing RHBDL2 (they took the "traffic cop" away).

• The Chaos: Without RHBDL2, the doorbells kept ringing. The cells got the "move and grow" signal constantly.
  • Migration: The cells started running around wildly, moving twice as fast as normal cells.
  • Invasion: When placed in a 3D gel (simulating tissue), these rogue cells invaded deep into the matrix, acting like an aggressive tumor.
  • Differentiation: When they tried to build a model of human skin, the cells couldn't organize properly. The layers were messy, and the skin didn't mature correctly.

The "Aha!" Moment: Why This Matters

This discovery changes how we think about skin biology and cancer.

1. The "Decoy" Strategy: We knew that in fruit flies, a similar protein helps start the signal. But in humans, RHBDL2 does the opposite: it stops the signal by creating a decoy. It's like having a bouncer who throws fake VIP passes out the door so the real VIPs can't get in.
2. The Calcium Connection: It explains how skin cells know when to stop moving and start hardening. The rise in calcium (a natural part of skin maturation) flips the switch on RHBDL2, which then shuts down the "growth" signal so the skin can finish its job.
3. Medical Implications: If RHBDL2 is broken, skin cells might keep moving and dividing when they shouldn't. This could be a hidden factor in skin cancers or poor wound healing. Understanding this "decoy" mechanism could help scientists design new drugs to either boost RHBDL2 (to stop cancer cells) or block it (to help wounds heal faster).

Summary

RHBDL2 is a calcium-activated protein in our skin that acts as a safety valve. It cuts the "growth signal" receptor (EGFR) off the cell surface and throws it into the space between cells. This floating piece acts as a decoy, soaking up the growth messages so the real receptors stay quiet. This ensures that skin cells stop moving and dividing when it's time to mature and form a protective barrier. Without this protein, skin cells become hyper-active, moving too fast and failing to form proper skin layers.

Technical Summary

1. Problem Statement

Epidermal Growth Factor Receptor (EGFR) signaling is critical for tissue homeostasis and morphogenesis but is frequently dysregulated in cancers. In Drosophila, rhomboid intramembrane proteases are the primary regulators of EGFR activation by cleaving ligand precursors. However, in mammals, this role is largely assumed by ADAM metalloproteases, leaving the physiological functions of mammalian secretory pathway rhomboid proteases (specifically RHBDL2) poorly understood. While RHBDL2 is known to be active and expressed in epithelial tissues, its native substrates and specific roles in human physiology remain ill-defined. The authors sought to identify the endogenous substrate repertoire of RHBDL2 in human epithelial cells and elucidate its biological function.

2. Methodology

The study employed a multi-faceted approach combining quantitative proteomics, cell biology, and in vivo modeling:

• Quantitative Proteomics (SILAC): The authors used Stable Isotope Labeling by Amino acids in Cell culture (SILAC) to compare the secretomes of wild-type (WT) HaCaT keratinocytes against RHBDL2-knockdown (R2kd) cells. They enriched for glycoproteins using lectin affinity chromatography to identify membrane proteins released into the media.
• Biochemical Characterization:
  • Cleavage Site Mapping: Using tandem affinity purification (His-Strep tags) and mass spectrometry, they identified the precise cleavage site of EGFR by RHBDL2.
  • Mutagenesis: They generated point mutants (e.g., A647P, G649P) to validate the cleavage site.
  • Inhibitor Studies: They utilized broad-spectrum metalloprotease inhibitors (BB94, GM6001), proteasome inhibitors, and lysosomal inhibitors (Bafilomycin A1) to determine the mechanism of EGFR shedding and the fate of the intracellular fragment.
  • Calcium Modulation: The effects of calcium ionophores (ionomycin, A23187), calcium chelators (BAPTA-AM, EGTA), and PLCγ activators (m-3M3FBS) were tested to assess calcium dependence.
• Cellular Assays:
  • Migration & Invasion: 2D migration (colony tracking, gap closure) and 3D invasion assays (spheroids in collagen matrix) were performed on WT and R2kd cells.
  • Signaling Analysis: Western blotting was used to measure phosphorylation levels of EGFR, Stat1, Stat3, ERK, and Akt.
  • Rescue Experiments: An inducible PiggyBac transposon system was used to re-express WT or catalytically inactive RHBDL2 in R2kd cells to confirm specificity.
• Primary Cell Models & Organotypic Cultures:
  • Experiments were validated in primary Normal Human Adult Epidermal Keratinocytes (NHEK-Ad) and immortalized Ker-CT cells.
  • CRISPR/Cas9 was used to generate RHBDL2-deficient N/TERT keratinocytes.
  • 3D Skin Equivalents: These cells were differentiated into organotypic skin cultures to assess histological architecture and differentiation markers (CK10, Filaggrin, Integrin α6).

3. Key Contributions

• Identification of EGFR as a Native Substrate: The study definitively identifies EGFR as the major endogenous substrate of RHBDL2 in human keratinocytes, a finding that contrasts with the ligand-shedding role of rhomboids in flies.
• Discovery of a Negative Feedback Mechanism: The authors reveal that RHBDL2 functions as a "decoy receptor" generator. By cleaving the EGFR ectodomain, it releases a soluble fragment that sequesters free EGFR ligands, thereby suppressing basal EGFR signaling.
• Calcium-Dependent Activation: The paper establishes that RHBDL2 activity is strictly regulated by intracellular calcium levels, linking protease activity to the calcium gradients known to drive keratinocyte differentiation.
• Physiological Relevance in Differentiation: The study demonstrates that RHBDL2 is essential for proper epidermal differentiation and tissue architecture, as its absence leads to disordered skin equivalents.

4. Key Results

• Proteomics: Quantitative proteomics identified EGFR and Trop2 as the most significantly enriched transmembrane proteins in the secretome of WT cells compared to R2kd cells.
• Mechanism of Shedding:
  • RHBDL2 cleaves EGFR within its transmembrane domain at the A647-T648 site.
  • This cleavage releases the ~100 kDa EGFR ectodomain into the media and targets the C-terminal intracellular fragment for lysosomal degradation.
  • Unlike in Drosophila, mammalian EGFR shedding in this context is independent of ADAM metalloproteases; in fact, inhibiting ADAMs increases RHBDL2-dependent shedding.
• Signaling Consequences:
  • Loss of RHBDL2 leads to increased basal phosphorylation of EGFR (Y992, Y1068) and downstream Stat3, but not ERK or Akt.
  • This hyperactivation drives increased cell migration and invasion.
• Calcium Regulation:
  • RHBDL2 activity is dramatically upregulated (approx. 10-fold) by sustained elevation of intracellular calcium (via ionomycin or PLCγ activation).
  • This effect is specific to EGFR shedding and requires extracellular calcium influx.
• Functional Phenotypes:
  • Migration/Invasion: R2kd cells migrate ~2x faster in 2D and show significantly increased invasion in 3D collagen matrices. This phenotype is rescued by WT RHBDL2 but not by the catalytically inactive S187T mutant.
  • Differentiation: In 3D skin equivalents, RHBDL2-deficient cultures exhibit morphological disorganization, loss of polarity in the basal layer, and impaired formation of the stratum corneum (parakeratosis). Molecular markers indicate premature or dysregulated differentiation.
• Ligand Sequestration Model: The soluble EGFR ectodomain acts as a decoy, binding free ligands (EGF, TGFα) and preventing them from activating membrane-bound EGFR. This mechanism is overridden when ligand concentrations are high (e.g., during wound healing), allowing signaling to proceed.

5. Significance

This paper redefines the role of mammalian rhomboid proteases in EGFR signaling. While previously thought to be redundant or minor players compared to ADAMs, RHBDL2 is shown to be a critical negative regulator of basal EGFR activity in keratinocytes.

• Physiological Homeostasis: RHBDL2 acts as a "brake" on EGFR signaling, preventing excessive proliferation and migration under basal conditions. Its calcium-dependent activation suggests it is a key switch that turns on during keratinocyte differentiation to dampen EGFR signaling, facilitating the transition from a proliferative state to a differentiated state.
• Pathological Implications: The findings suggest that RHBDL2 dysfunction could contribute to skin disorders characterized by defective differentiation or hyper-proliferation (e.g., psoriasis or certain skin cancers).
• Evolutionary Insight: The study highlights an evolutionary divergence where mammalian rhomboids have shifted from cleaving ligands (as in flies) to cleaving the receptor itself, providing a novel layer of fine-tuning for autocrine signaling loops.
• Therapeutic Potential: Understanding this calcium-activated shedding mechanism offers new avenues for targeting EGFR signaling in cancer or regenerative medicine, particularly by modulating the decoy receptor pool.